pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3937 |
Genomic Coordinates | chrX: 39661216 - 39661321 |
Description | Homo sapiens miR-3937 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3937 | |||||||||||||||||||||
Sequence | 61| ACAGGCGGCUGUAGCAAUGGGGG |83 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CLSTN1 | ||||||||||||||||||||
Synonyms | ALC-ALPHA, CDHR12, CST-1, CSTN1, PIK3CD, XB31alpha, alcalpha1, alcalpha2 | ||||||||||||||||||||
Description | calsyntenin 1 | ||||||||||||||||||||
Transcript | NM_001009566 | ||||||||||||||||||||
Other Transcripts | NM_014944 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CLSTN1 | |||||||||||||||||||||
3'UTR of CLSTN1 (miRNA target sites are highlighted) |
>CLSTN1|NM_001009566|3'UTR 1 CCCGTGCCCCCGGCCACCTCGGTTTCTGCTTTCGAAGACTCTGCTGCCATCCGTTCTCCCAGTCCCAAGGGTCCACGATG 81 TACAAAGTCATTTCGGCCAGTAGGTGTGCAGACCCCTCCCCGCCACGATCGTCGCTGTGCTTGGTGTGTAGGACCCTAGG 161 CTCCCCGCCCACCCTCTGCCTGGTCGCGCTCTTCAGTCCCACGAGGAGCTGACACGTCCTCTCTGGCCGCCATCCGGCTC 241 GCACAGGGGCCTCCCAGCGCCTCAGGCCCCGCGTTTGTGTCTGGAGTCTCCCCCCGGGGAGAGGACACTGGCCCCTCGCA 321 CTCCAGAAAAGCCATGCCAGCTGGGCTCGTTGACAAAGGGTAAAACATGCTCACTCCCACCCGGTAATCATTTTTTTCTT 401 TTTTTAAAAAAAGTTTTTATTTTTTCCAAACTAGTGCATGTATAAATAATGGCAGGATGGGGGGTACTGTGTAGATGATT 481 AACTGACTTTTTAATATTTTGTAAATAAATCGGATTCCTTGTGTCCTTTGTGCTAGTGTAACCCGGGACTGGAATGTAAA 561 GTGAAGTTCGGAGCTCTGAGCACGGGCTCTTCCCGCCGGGTCCTCCCTCCCCAGACCCCAGAGGGAGAGGCCCACCCCGC 641 CCAGCCCCGCCCCAGCCCCTGCTCAGGTCTGAGTATGGCTGGGAGTCGGGGGCCACAGGCCTCTAGCTGTGCTGCTCAAG 721 AGACTGGATCAGGGTAGCTACAAGTGGCCGGGCCTTGCCTTTGGGATTCTACCTGTTCCTAATTTGGTGTGGGGTGCGGG 801 GTCCCTGGCCCCTTTTCCACACTCCTCCTCCGACAGCAGCTCCCTGGGCAGTGGCCTGGTCTCACCGTGTGCAGCCTTGT 881 GGTTTATGCTTAAATGTACATTTTCCTGCTGGTAAAAGGAGAAACTGAGAGGTGTCCTGCAGACCGGCTGACCACTCCTT 961 TTGGAGACGGCAGGAGGCCTGAGCGATCCGTACTCAGAACGTCCAGGAGAGACGCATGGCCCGAAGTCAAAGTGCTGGAA 1041 TTTTCCAAAACAGCCTGTTCTCTCCTCTCTCCTCCCCAGAGCACCCCCTGCCATCAGGGGGGTTGAAATCCCTCTCCCCC 1121 AGGAGCCCTGCTGCTTTGCTTGGTGGTAGGGCAGGAGAGCAAACAAACAGTCATGGTCTAAAACCCACATAGCACTTTGC 1201 TCTTAGTTACATGTAAAATTTTAGATTTCTAAAACAGGTGGGCAATCATTTTGAATACTGTTCTGTGACCCTGACTGCTA 1281 GTTCTGAGGACACTGGTGGCTGTGCTATGTGTGGCCATCCTCCATGTCCCGTCCCTGTAGCTGCTCTGTTTAGACAGCGG 1361 ACAGACGCTCACGCCCAGGGGATGTCCTCACGCTGTCGCCGCGCGGTTTCCCTTCGCAGATGTGTATACTCATGATAGGT 1441 CAGAAAGTGTATCCGCTACAATAAAGTTCTGGTTCTAACTAACTCCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293S | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084046. RNA binding protein: AGO2. Condition:CLIP_noarsenite_rep4
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084046 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noarsenite_rep4 |
Location of target site | ENST00000536656.1 | 3UTR | UGAGCCUCCCAAAGUGCUGGGAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
40 hsa-miR-3937 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT332487 | CD81 | CD81 molecule | 2 | 2 | ||||||||
MIRT441327 | NDUFA11 | NADH:ubiquinone oxidoreductase subunit A11 | 2 | 4 | ||||||||
MIRT454032 | EIF3CL | eukaryotic translation initiation factor 3 subunit C like | 2 | 2 | ||||||||
MIRT458086 | EIF3C | eukaryotic translation initiation factor 3 subunit C | 2 | 2 | ||||||||
MIRT460785 | VPS37B | VPS37B, ESCRT-I subunit | 2 | 2 | ||||||||
MIRT463150 | ZNF385A | zinc finger protein 385A | 2 | 4 | ||||||||
MIRT467162 | SREBF2 | sterol regulatory element binding transcription factor 2 | 2 | 2 | ||||||||
MIRT469618 | RAI1 | retinoic acid induced 1 | 2 | 4 | ||||||||
MIRT472258 | NFIC | nuclear factor I C | 2 | 2 | ||||||||
MIRT487587 | FAM83H | family with sequence similarity 83 member H | 2 | 4 | ||||||||
MIRT489302 | B4GALNT4 | beta-1,4-N-acetyl-galactosaminyltransferase 4 | 2 | 4 | ||||||||
MIRT489741 | GNAI2 | G protein subunit alpha i2 | 2 | 4 | ||||||||
MIRT490038 | PCSK4 | proprotein convertase subtilisin/kexin type 4 | 2 | 2 | ||||||||
MIRT490767 | SRCIN1 | SRC kinase signaling inhibitor 1 | 2 | 2 | ||||||||
MIRT491750 | SEMA3F | semaphorin 3F | 2 | 2 | ||||||||
MIRT492690 | PHYHIP | phytanoyl-CoA 2-hydroxylase interacting protein | 2 | 2 | ||||||||
MIRT504843 | RRP36 | ribosomal RNA processing 36 | 2 | 4 | ||||||||
MIRT510116 | IRAK3 | interleukin 1 receptor associated kinase 3 | 2 | 8 | ||||||||
MIRT525313 | FANCA | Fanconi anemia complementation group A | 2 | 4 | ||||||||
MIRT569801 | IGDCC3 | immunoglobulin superfamily DCC subclass member 3 | 2 | 2 | ||||||||
MIRT570224 | SLC27A1 | solute carrier family 27 member 1 | 2 | 2 | ||||||||
MIRT629378 | FAHD1 | fumarylacetoacetate hydrolase domain containing 1 | 2 | 2 | ||||||||
MIRT633104 | CBX5 | chromobox 5 | 2 | 2 | ||||||||
MIRT645036 | ATAD3C | ATPase family, AAA domain containing 3C | 2 | 2 | ||||||||
MIRT660973 | ABI2 | abl interactor 2 | 2 | 2 | ||||||||
MIRT671225 | CLSTN1 | calsyntenin 1 | 2 | 2 | ||||||||
MIRT672046 | SMTNL2 | smoothelin like 2 | 2 | 2 | ||||||||
MIRT677314 | CPSF2 | cleavage and polyadenylation specific factor 2 | 2 | 2 | ||||||||
MIRT678290 | PTRH2 | peptidyl-tRNA hydrolase 2 | 2 | 2 | ||||||||
MIRT693477 | ZNF707 | zinc finger protein 707 | 2 | 2 | ||||||||
MIRT693576 | PIGR | polymeric immunoglobulin receptor | 2 | 2 | ||||||||
MIRT696832 | PLLP | plasmolipin | 2 | 2 | ||||||||
MIRT700149 | RNF115 | ring finger protein 115 | 2 | 2 | ||||||||
MIRT703760 | FAM118A | family with sequence similarity 118 member A | 2 | 2 | ||||||||
MIRT705798 | ALDH6A1 | aldehyde dehydrogenase 6 family member A1 | 2 | 2 | ||||||||
MIRT709105 | SEPT4 | septin 4 | 2 | 2 | ||||||||
MIRT710235 | ARMCX6 | armadillo repeat containing, X-linked 6 | 2 | 2 | ||||||||
MIRT711422 | EPHA4 | EPH receptor A4 | 2 | 2 | ||||||||
MIRT712529 | CYTH2 | cytohesin 2 | 2 | 2 | ||||||||
MIRT714081 | ZNF532 | zinc finger protein 532 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|